Toothy AI vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 21)

Toothy AI

EmergingHealthcare

Dental AI

Toothy AI is a dental AI platform that uses computer vision to analyze dental X-rays, helping dentists detect cavities, bone loss, and other dental pathology more accurately. HQ: San Francisco.

AI VisibilityBeta
Overall Score
D21
Category Rank
#1 of 1
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
23
Perplexity
16
Gemini
13

About

Toothy AI is a dental AI company applying computer vision to the analysis of dental radiographs (bitewing X-rays, periapical X-rays, panoramic scans), helping dentists detect caries (cavities), bone loss, failing restorations, and other pathology more reliably and consistently. Dental AI image analysis is a high-value application: dental X-rays are taken at virtually every dental visit, the findings have direct treatment implications, and research has shown that dentists' detection rates for early-stage caries can vary significantly based on experience and reading conditions.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

21
Overall Score
90
#1
Category Rank
#83
68
AI Consensus
58
stable
Trend
stable
23
ChatGPT
84
16
Perplexity
97
13
Gemini
99
19
Claude
86
26
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.